{"title":"Dual role mechanisms of regulated cell death in apical periodontitis: from pathogenic destruction to therapeutic potential.","authors":"Yu Cao, Shipeng Yang, Quzhen Baima, Yuqi Zhen, Xinyue Hang, Xiuping Meng","doi":"10.1038/s41420-025-02686-4","DOIUrl":null,"url":null,"abstract":"<p><p>Apical periodontitis (AP), a highly prevalent infectious disease driven by pathogenic microorganisms residing in periapical tissues, orchestrates a dynamic interplay between microbial virulence and host immune defenses. Emerging evidence indicates that these pathogens critically manipulate regulated cell death (RCD) pathways to subvert immune surveillance and dictate periapical bone remodeling outcomes. While RCD has traditionally been viewed as a dichotomy between pro-inflammatory destruction and anti-inflammatory repair, recent advances reveal its context-dependent duality, shaped by microbial-immune crosstalk. Despite growing interest in this field, current literature lacks a comprehensive synthesis delineating the dual-pathological impact of RCD mechanisms in AP progression, particularly their beneficial versus detrimental roles. This review critically evaluates the molecular mechanisms of RCD and crosstalk among its forms, delineating its dual roles in immune defense versus bone destruction during AP progression. We synthesize current understanding of RCD pathways in AP pathogenesis and explore therapeutically targeting these mechanisms to modulate disease outcomes. Furthermore, we explore the feasibility of developing therapeutic strategies for AP based on RCD targets and propose novel research directions to advance understanding and treatment of this condition.</p>","PeriodicalId":9735,"journal":{"name":"Cell Death Discovery","volume":"11 1","pages":"386"},"PeriodicalIF":7.0000,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12356886/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell Death Discovery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41420-025-02686-4","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Apical periodontitis (AP), a highly prevalent infectious disease driven by pathogenic microorganisms residing in periapical tissues, orchestrates a dynamic interplay between microbial virulence and host immune defenses. Emerging evidence indicates that these pathogens critically manipulate regulated cell death (RCD) pathways to subvert immune surveillance and dictate periapical bone remodeling outcomes. While RCD has traditionally been viewed as a dichotomy between pro-inflammatory destruction and anti-inflammatory repair, recent advances reveal its context-dependent duality, shaped by microbial-immune crosstalk. Despite growing interest in this field, current literature lacks a comprehensive synthesis delineating the dual-pathological impact of RCD mechanisms in AP progression, particularly their beneficial versus detrimental roles. This review critically evaluates the molecular mechanisms of RCD and crosstalk among its forms, delineating its dual roles in immune defense versus bone destruction during AP progression. We synthesize current understanding of RCD pathways in AP pathogenesis and explore therapeutically targeting these mechanisms to modulate disease outcomes. Furthermore, we explore the feasibility of developing therapeutic strategies for AP based on RCD targets and propose novel research directions to advance understanding and treatment of this condition.
期刊介绍:
Cell Death Discovery is a multidisciplinary, international, online-only, open access journal, dedicated to publishing research at the intersection of medicine with biochemistry, pharmacology, immunology, cell biology and cell death, provided it is scientifically sound. The unrestricted access to research findings in Cell Death Discovery will foster a dynamic and highly productive dialogue between basic scientists and clinicians, as well as researchers in industry with a focus on cancer, neurobiology and inflammation research. As an official journal of the Cell Death Differentiation Association (ADMC), Cell Death Discovery will build upon the success of Cell Death & Differentiation and Cell Death & Disease in publishing important peer-reviewed original research, timely reviews and editorial commentary.
Cell Death Discovery is committed to increasing the reproducibility of research. To this end, in conjunction with its sister journals Cell Death & Differentiation and Cell Death & Disease, Cell Death Discovery provides a unique forum for scientists as well as clinicians and members of the pharmaceutical and biotechnical industry. It is committed to the rapid publication of high quality original papers that relate to these subjects, together with topical, usually solicited, reviews, editorial correspondence and occasional commentaries on controversial and scientifically informative issues.